SearcharxivSearch

arXiv subjects

Deb Schrag

Publications and source records attributed to Deb Schrag.

2 recordsLinked to original sources

Average Cause-Specific Hazard: A Censoring-Invariant Measure of Event Burden Under Competing Risks

Competing events are common in clinical and epidemiologic studies, including semi-competing risks in which a terminal event such as death may follow a nonfatal event but also competes with it beforehand. Standard summaries include the cumulative incidence function (CIF) and the incidence rate (IR), defined as the number of observed events divided by observed event-free person-time. With competing events, the naive IR generally depends on the censoring-time distribution unless intensities are constant. We propose the Average Cause-Specific Hazard (ACSH), a survival-weighted rate per event-free person-time that preserves the interpretation of an incidence rate and is defined purely from the event-time distribution, without involving the censoring-time distribution. We develop nonparametric estimation and inference for ACSH and, for two-sample comparisons, introduce ACSH differences and ratios that provide interpretable contrasts without requiring a strong model assumption between two groups. Simulation studies examine the finite-sample performance, and an analysis of the CANVAS trial illustrates the proposed methods.

stat.ME

Comparative Effectiveness Research with Average Hazard for Censored Time-to-Event Outcomes: A Numerical Study

The average hazard (AH), recently introduced by Uno and Horiguchi, represents a novel summary metric of event time distributions, conceptualized as the general censoring-free average person-time incidence rate on a given time window, $[0,\tau].$ This metric is calculated as the ratio of the cumulative incidence probability at $\tau$ to the restricted mean survival time at $\tau$ and can be estimated through non-parametric methods. The AH's difference and ratio present viable alternatives to the traditional Cox's hazard ratio for quantifying the treatment effect on time-to-event outcomes in comparative clinical studies. While the methodology for evaluating the difference and ratio of AH in randomized clinical trials has been previously proposed, the application of the AH-based approach in general comparative effectiveness research (CER), where interventions are not randomly allocated, remains underdiscussed. This paper aims to introduce several approaches for applying the AH in general CER, thereby extending its utility beyond randomized trial settings to observational studies where treatment assignment is non-random.

stat.AP